electroCore (ECOR) Net Income towards Common Stockholders (2017 - 2026)

electroCore's (ECOR) quarterly Net Income towards Common Stockholders came in at -$5.3 million in Q1 2026, down 36.73% year-on-year from -$8.3 million in Q1 2025, and down 149.31% quarter-over-quarter from $10.7 million in Q4 2025.

electroCore (ECOR) Net Income towards Common Stockholders (2017 - 2026) Analysis & Trends

electroCore's Net Income towards Common Stockholders history runs 10 years deep, the most recent figure standing at -$5.3 million for Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders fell 36.73% year-over-year to -$5.3 million in Q1 2026; TTM through Mar 2026 was -$1.7 million, a 85.7% increase from a year earlier, with the FY2025 full-year figure at -$242000.0, up 97.85% from the prior year.
  • Net Income towards Common Stockholders eased to -$5.3 million in Q1 2026 per ECOR's latest filing, from $10.7 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $10.7 million in Q4 2025 and bottomed at -$5.9 million in Q1 2023.
  • The 5-year median for Net Income towards Common Stockholders is -$3.9 million (2025), against an average of -$3.4 million.
  • Across the five-year window, Net Income towards Common Stockholders sank 149.35% in 2022 and soared 513.18% in 2025, its largest moves.
  • Year by year, Net Income towards Common Stockholders stood at -$5.8 million in 2022, then jumped by 35.66% to -$3.7 million in 2023, then soared by 30.55% to -$2.6 million in 2024, then surged by 513.18% to $10.7 million in 2025, then plunged by 149.31% to -$5.3 million in 2026.
  • Per Business Quant, the three latest ECOR Net Income towards Common Stockholders figures stand at -$5.3 million (Q1 2026), $10.7 million (Q4 2025), and -$3.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 184.15 Bn 176.85 Bn 6.27 Bn 1.08 Bn
2 Stryker 128.85 Bn 125.98 Bn 3.81 Bn 745.00 Mn
3 Medtronic 108.75 Bn 99.53 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 68.66 Bn 67.21 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.24 Bn 44.57 Bn 1.29 Bn -
6 Dexcom 28.42 Bn 27.30 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 28.32 Bn 26.03 Bn 1.98 Bn 411.00 Mn
8 Smith & Nephew 26.93 Bn 26.35 Bn - -
9 Koninklijke Philips 25.31 Bn 22.18 Bn 2.07 Bn 176.78 Mn
10 electroCore 55,284.78 -8.77 Mn 8.36 Mn -5.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.27 Mn
Dec 31, 2025 10.69 Mn
Sep 30, 2025 -3.41 Mn
Jun 30, 2025 -3.67 Mn
Mar 31, 2025 -3.86 Mn
Dec 31, 2024 -2.59 Mn
Sep 30, 2024 -2.50 Mn
Jun 30, 2024 -2.66 Mn
Mar 31, 2024 -3.51 Mn
Dec 31, 2023 -3.73 Mn
Sep 30, 2023 -4.03 Mn
Jun 30, 2023 -4.90 Mn
Mar 31, 2023 -5.87 Mn
Dec 31, 2022 -5.79 Mn
Sep 30, 2022 -5.45 Mn
Jun 30, 2022 -5.34 Mn
Mar 31, 2022 -5.58 Mn
Dec 31, 2021 11.73 Mn
Sep 30, 2021 -3.99 Mn
Jun 30, 2021 -2.89 Mn